Kesler Norman & Wride’s Medpace MEDP Stock Holding History

Kesler Norman & Wride’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,131	Closed	-$379K	–	238
2024 Q3	$379K	Buy	+1,131	New	+$430K	0.07%	196

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Kesler Norman & Wride's MEDP Position: Q4 2024 in Review

Kesler Norman & Wride sold out of Medpace (MEDP) in Q4 2024, closing a stake of 1,131 shares — an estimated $379K sold.

Kesler Norman & Wride first reported a position in MEDP in Q3 2024 and held it in 1 quarter. The position peaked at $379K in Q3 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

Kesler Norman & Wride reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
Kesler Norman & Wride sold 1,131 Medpace shares in Q4 2024, an estimated $379K.
Kesler Norman & Wride first reported a position in Medpace in Q3 2024 and held it in 1 quarter.
Kesler Norman & Wride's Medpace position peaked at $379K in Q3 2024.
592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Kesler Norman & Wride's 13F filing for Q4 2024, filed 12 Feb 2025.